-transparent.png){kind=logo}
In a retrospective study 80 patients with Hodgkin's disease of stage III B (n = 32) and IV (n = 48) were investigated, who had been treated with a modified MOPP regimen. 28 patients (35%) were previously untreated. A completed remission was reached in 51 patients, a partial remission in 16, and 13 patients failed to respond. 16 patients had died in the observation period. Complete remissions were twice as frequent with 90% in stage III as compared with 45% in stage IV. The group of patients surviving 4 years was 92% in stage III and 62% in stage IV.
Related Publications
F J Tigges, and
E Hiller, and
R M Schmülling, and
H D Waller, and
K Wilms
January 1985,
Haematologica,
F J Tigges, and
E Hiller, and
R M Schmülling, and
H D Waller, and
K Wilms
August 1976,
Deutsche medizinische Wochenschrift (1946),
F J Tigges, and
E Hiller, and
R M Schmülling, and
H D Waller, and
K Wilms
September 1987,
Revista medica de Chile,
F J Tigges, and
E Hiller, and
R M Schmülling, and
H D Waller, and
K Wilms
March 1987,
Blut,
F J Tigges, and
E Hiller, and
R M Schmülling, and
H D Waller, and
K Wilms
March 1981,
Klinische Wochenschrift,
F J Tigges, and
E Hiller, and
R M Schmülling, and
H D Waller, and
K Wilms
February 1981,
Wiener klinische Wochenschrift,
F J Tigges, and
E Hiller, and
R M Schmülling, and
H D Waller, and
K Wilms
May 1979,
Cancer,
F J Tigges, and
E Hiller, and
R M Schmülling, and
H D Waller, and
K Wilms
June 1980,
MMW, Munchener medizinische Wochenschrift,
F J Tigges, and
E Hiller, and
R M Schmülling, and
H D Waller, and
K Wilms
August 1991,
Journal of clinical oncology : official journal of the American Society of Clinical Oncology,
F J Tigges, and
E Hiller, and
R M Schmülling, and
H D Waller, and
K Wilms
January 1984,
Hematological oncology,
